Opaleye Management Inc. Fennec Pharmaceuticals Inc. Transaction History

Opaleye Management Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$7.63 - $10.22 $2.08 Million - $2.78 Million	272,200 New	272,200 $2.61 Million
Q3 2020 Nov 16, 2020	SELL	$5.19 - $10.17 $887,490 - $1.74 Million	-171,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.43 - $9.39 $928,530 - $1.61 Million	171,000 New	171,000 $1.43 Million
Q1 2020 May 15, 2020	SELL	$4.89 - $8.1 $58,679 - $97,200	-12,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $51,000 - $77,880	12,000 New	12,000 $78,000
Q3 2019 Nov 14, 2019	SELL	$3.85 - $4.95 $1.14 Million - $1.46 Million	-295,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$3.3 - $5.09 $1.11 Million - $1.71 Million	-335,000 Reduced 53.17%	295,000 $1.18 Million
Q1 2019 May 15, 2019	SELL	$4.64 - $7.58 $1.25 Million - $2.05 Million	-270,000 Reduced 30.0%	630,000 $3.06 Million
Q4 2018 Feb 14, 2019	SELL	$5.37 - $8.39 $402,750 - $629,250	-75,000 Reduced 7.69%	900,000 $5.74 Million
Q3 2018 Nov 14, 2018	BUY	$7.84 - $10.83 $235,200 - $324,900	30,000 Added 3.17%	975,000 $8 Million
Q2 2018 Aug 14, 2018	BUY	$10.05 - $14.33 $723,600 - $1.03 Million	72,000 Added 8.25%	945,000 $9.87 Million
Q1 2018 May 14, 2018	BUY	$8.26 - $12.1 $215,586 - $315,810	26,100 Added 3.08%	873,000 $10.6 Million
Q4 2017 Feb 09, 2018	BUY	$8.9 - $12.35 $7.54 Million - $10.5 Million	846,900	846,900 $8.49 Million

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $173M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.